期刊文献+

喉黏膜间充质干细胞肌向分化的实验研究

Myogenic differentiation of laryngeal mucosal mesenchymal stem cells
原文传递
导出
摘要 目的 将喉黏膜间充质干细胞(laryngeal mucosal mesenchymal stem cells,LM-MSC)向成肌细胞诱导分化,为声带部分或全部缺失的组织工程修复寻求优势种子细胞.方法 从正常会厌舌面黏膜分离培养获得LM-MSC,流式细胞仪检测细胞表面分子标志CD44、CD105、CD90、CD29、CD34和CD45;向成脂、成骨细胞分化鉴定细胞多向分化潜能,油红O、茜素红染色鉴定成脂、成骨分化情况;加入成肌诱导液向成肌细胞方向分化,于成肌诱导分化后1周和3周时行免疫荧光化学染色,诱导后1周、3周和6周行实时定量RT-PCR分析,以分别定性和定量分析成肌分化相关蛋白及基因Myod1、Myogenin、肌球蛋白重链(myosin heavy chain,MyHc)的表达.结果 本实验分离培养获得的LM-MSC可贴壁生长,呈长梭形;高表达间充质干细胞表面分子标志物:CD44(100.0%),CD105(90.4%),CD90(99.9%),CD29 (93.0%),低表达造血系干细胞表面分子标志物:CD34(0.4%)和CD45(1.3%);LM-MSC在体外定向向成脂、成骨分化14 d和21 d后有大量串珠样脂滴和矿化结节生成;成肌细胞初始标志蛋白Myod1和特异性标志蛋白Myogenin,MyHc分别于成肌诱导分化后1周和3周出现,RT-PCR结果与免疫荧光化学染色结果一致,并且相关基因持续表达于成肌诱导分化后6周.结论 LM-MSC符合间充质干细胞的特性,并可定向分化为成肌细胞,有潜能成为声带组织工程修复的优势种子细胞. Objective To investigate the myogenic differentiation of laryngeal mucosal mesenchymal stem cells (LM-MSCs) and the possibility of LM-MSCs as new alternative seed cells for laryngeal tissue engineering.Methods LM-MSCs were separated from normal epiglottis mucosa and the cell surface markers including CD44,CD105,CD90,CD29,CD34 and CD45 were analyzed through flow cytometry.The osteogenesis and adipogenesis differentiation of LM-MSCs were investigated by oil red staining and alizarin red S staining.Immunofluorescence staining and RT-PCR were used to detect the expressions of myogenic differentiation markers including Myod1,Myogenin and myosin heavy chain (MyHc).Results The separated LM-MSCs were in a fibrocyte-like form with long fusiform shape and grew adherently.The expression rates of cell surface markers LM-MSCs were CD44 (100.0%),CD105 (90.4%),CD90 (99.9%),CD29 (93.0%),CD34 (0.4%) and CD45 (1.3%) respectively.A number of beaded lipid drops and mineral deposition were observed after 14 days of adipogenesis differentiation and 21 days of osteogenesis differentiation.Myod1,Myogenin and MyHc genes appeared after 1 week and 3 weeks of myogenesis differentiation respectively.Conclusions The LM-MSCs have the properties of mesenchymal stem cells and could be differentiated into myoblasts,providing with the possibility to repair the damaged vocal cords with LM-MSCs through tissue engineering techniques.
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2014年第6期473-478,共6页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
基金 国家自然科学基金(81271065)
关键词 喉黏膜 间充质干细胞 声带 成肌细胞 细胞分化 Larnyngeal mucosa Mesenchymal stem cell Vocal cords Myoblasts Cell differentiation
  • 相关文献

参考文献20

  • 1Milovanovic JP,Djukic VB,Milovanovic AP,et al.Functional results of treatment of early carcinoma in the glottic region of the larynx[J].Acta Chir lugosl,2009,56 (3):95-100.
  • 2Arnold A.Grossman.A method for the surgical correction of bilateral abductor vocal cord paralysis[J].Can Med Assoc J,1954,70 (5):521-525.
  • 3Thibeault SL,Klemuk SA,Chen X,et al.In vivo engineering of the vocal fold ECM with injectable HA hydrogels-late efdects on tissue repair and biomechanics in a rabbit model[J].J Voice,2010,12(2):123-131.
  • 4Bartlett RS,Thibeault SL,Prestwich GD.Therapeutic potential of gel-based injectables for vocal fold regeneration[J].Biomed Mater,2012,7(2):024103.
  • 5Kanemaru S,Nakamura T,Yamashita M,et al.Destiny of autologous bone marrow-derived stromal cells implanted in the vocal fold[J].Ann Otol Rhinol Laryngol,2005,114 (12):907-912.
  • 6da Sliva Meirelles L,Chagastelles PC,Nardi NB.Mesenchymal stem cells reside in virtually all post-natal organs and tissues[J].J Cell Sci,2006,119(Pt 11):2204-2213.
  • 7刘阳,韩鹏,梁媛媛,邓志宏.不同部位喉黏膜间充质细胞的分离培养[J].现代生物医学进展,2011,11(8):1440-1442. 被引量:3
  • 8刘阳,梁强,梁媛媛,邓志宏.喉黏膜间充质干细胞的分离培养及鉴定[J].中华耳鼻咽喉头颈外科杂志,2011,46(5):408-412. 被引量:3
  • 9Peng H,Ming L,Yang R,et al.The use of laryngeal mucosa mesenchymal stem cells for the repair the vocal fold injury[J].Biomaterials,2013,34 (36):9026-9035.
  • 10Havis E,Coumailleau P,Bonnet A,et al.Sim2 prevents entry into the myogenic program by repressing MyoD transcription during limb embryonic myogenesis[J].Development,2012,139 (11):1910-1920.

二级参考文献47

  • 1张雷,汤建国.声带瘢痕的概念与对策[J].中华耳鼻咽喉头颈外科杂志,2005,40(4):314-317. 被引量:23
  • 2Strasser H,Marksteiner R,Margreiter E,et al.Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women:a randomised controlled trial[J].Lancet,2007,369(9580):2179-2186.
  • 3Mitterberger M,Marksteiner R,Margreiter E,et al.Autologous myoblasts and fibroblasts for female stress incontinence:a 1-year follow-up in 123 patients[J].BJU Int,2007,100(5):1081-1085.
  • 4Mitterberger M,Pinggera GM,Marksteriner R,et al.Adult stem cell therapy of female stress urinary incontinence[J].Eur Urol,2008,53(1):169-175.
  • 5Luber KM.The definition,prevalence and risk factors for stress urinary incontinence[J].Rev Urol,2004,6(Suppl 3):S3-S9.
  • 6Abrams P,Cardozo L,Fall M,et al.The standardisation of terminology in lower urinary tract function:report from the standardisation sub-committee of the International Continence Society[J].Urology,2003,61(1):37-49.
  • 7Kayigil O,Iftekhar Ahmed S,Metin A.The coexistence of intrinsic sphincter deficiency with type II stress incontinence[J].J Urol,1999,162(4):1365-1366.
  • 8Strasser H,Berjukow S,Marksteiner R,et al.Stem cell therapy for urinary stress incontinence[J].Exp Gerontol,2004,39(9):1259-1265.
  • 9Mitterberger M,Pinggera GM,Marksteiner R,et al.Functional and histological changes after myoblast injections in the porcine rhabdosphincter[J].Eur Urol,2007,52(6):1736-1743.
  • 10Wakitani S,Saito T,Caplan AI.Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine[J].Muscle Nerve,1995,18(12):1417-1426.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部